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Abstract
Background: Immunosenescence is the age-related decline and dysfunction of protective immunity leading to a
marked increase in the risk of infections, autoimmune disease, and cancer. The majority of studies have focused on
immunosenescence in the systemic immune system; information concerning the effect of aging on intestinal
immunity is limited. Isolated lymphoid follicles (ILFs) are newly appreciated dynamic intestinal lymphoid structures
that arise from nascent lymphoid tissues, or cryptopatches (CP), in response to local inflammatory stimuli. ILFs
promote “homeostatic” responses including the production of antigen-specific IgA, thus playing a key role in
mucosal immune protection. ILF dysfunction with aging could contribute to immunosenescence of the mucosal
system, and accordingly we examined phenotypic and functional aspects of ILFs from young (2 month old) and
aged (2 year old) mice.
Results: We observed that aged mice have increased numbers of ILFs and increased numbers of structures
corresponding to an early stage of CPs transforming into ILFs. The cellular composition of ILFs in aged mice is
altered with a smaller B-lymphocyte population and an increased T-lymphocyte population. The ILF T-lymphocyte
population is notable by the presence of CD4+ CD8aa+ T-lymphocytes, which are absent from the systemic
compartment. The smaller B-lymphocyte population in ILFs from aged mice is directly correlated with decreased
mRNA and protein expression of CCL20 and CXCL13, two chemokines that play crucial roles in recruiting B-
lymphocytes into ILFs. Aged mice had elevated levels of serum and fecal immunoglobulins and despite the
decreased B-lymphocyte population, ILFs from aged mice displayed increased IgA production. The immunoglobulin
repertoire was skewed in aged mice, and ILFs demonstrated a repertoire usage similar to that of the systemic pool
in both young and aged mice.
Conclusions: Here we observed that ILF development, cellular composition, and immunoglobulin production are
altered with aging suggesting that ILF dysfunction contributes to mucosal immunosenescence.
Background
Immunosenescence is the age-related decline and dys-
function in protective immunity with serious clinical
consequences [1-4]. With aging, bacterial and viral
infections in the lungs, skin, and urinary tract become
more common [5-7]. Compounding this susceptibility to
infection, the rates of seroconversion after prophylactic
vaccination decrease proportionally with advancing age
[8,9]. Related to the decreased ability to mount effective
immune responses to pathogens, immunosenescence
also leads to a decline in effective immune surveillance
potentiating an increased incidence of malignancy [10].
Finally, immunosenescence is not only associated with
declining host immune competence, but also with
immune dysregulation manifested by an increased inci-
dence in autoimmune and chronic inflammatory disor-
ders with increasing age [11].
Despite the earlier thoughts that the mucosal immune
compartment was largely unaffected by aging, the muco-
sal immune response is now believed to be compro-
mised in old animals and elderly humans [12-14]. The
impact of mucosal immunosenescence is highlighted by
epidemiological studies demonstrating a marked
increase in mortality due to gastrointestinal infections in
the elderly in comparison to young adults [13]. Likewise,
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age is also an important risk factor for colon cancer, the
third most deadly cancer in the United States. Coinci-
dent with this decline is an increased incidence of indi-
viduals diagnosed with inflammatory bowel disease in
their seventh decade of life, thus demonstrating a ten-
dency toward the development of inappropriate mucosal
immune responses with aging [15,16].
The mucosal immune system is a complex network
generating immune responses that both protect the host
and mitigate potential damage due to uncontrolled
inflammation [17,18]. In the gastrointestinal tract this
system includes diffuse effector sites, such as the intest-
inal lamina propria (LP) and the intraepithelial lympho-
cyte (IEL) compartment, as well as organized lymphoid
structures that are collectively referred to as the gastroin-
testinal-associated lymphoid tissue (GALT). Isolated lym-
phoid follicles have recently become appreciated as
distinct members of the GALT. ILFs resemble Peyer’s
patches (PPs), the most widely studied lymphoid struc-
ture in the small intestine, in architecture and cellular
composition. Like PPs, ILFs can possess germinal centers
and an overlying follicle-associated epithelium (FAE)
containing M cells [19]. In contrast to PP, whose forma-
tion is developmentally driven, with early vital events
occurring only during embryogenesis, ILFs develop after
birth and arise from nascent lymphoid tissues, or crypto-
patches (CPs), in response to luminal stimuli including
alterations in the intestinal microbiota [19,20]. The adult
murine intestine contains ~1000 CP, and thus in compar-
ison to the relatively small (~10) fixed number of PP,
there is potentially a much greater number of the ILFs
that can contribute to mucosal immune responses. The
function of CP and ILFs are incompletely understood.
ILFs, but not CP, are known to act as sites for the induc-
tion of adaptive immune responses [21], and studies of
young animals demonstrate that ILFs function in a com-
pensatory manner, promoting ‘homeostatic’ responses to
local inflammatory stimuli including the production of
antigen specific IgA [22]. Therefore a dysfunction in ILF
development or function with aging has the potential to
contribute to the immunosenescence of the intestinal
immune system in a substantial way.
To gain insight into the role the ILFs play in intestinal
immunosenescence, we examined the phenotypic and
functional aspects of ILFs from aged and young mice. To
our surprise, we observed an increase in the number of
structures corresponding to transitioning CP and ILFs
with aging. However, consistent with immune dysfunc-
tion with aging, we found that ILFs from aged mice had a
smaller B-lymphocyte population and an increased T-
lymphocyte population when compared with their young
counterparts. This finding correlated with decreased
expression of the chemokines CXCL13 and CCL20,
known to be important in recruiting B-lymphocytes into
ILFs, and decreased expression of their corresponding
ligands, CXCR5 and CCR6, in ILFs of aged mice. Further
analysis of the ILF T-lymphocyte population in aged
mice revealed additional abnormalities characterized by
the presence of a unique CD4+ CD8aa+ T-lymphocyte
population. In agreement with prior observations, we
found that the serum immunoglobulin levels in the aged
mice were significantly increased and that fecal IgA levels
were elevated with aging. Consistent with ILFs contribut-
ing to dysfunction of the mucosal immune system with
aging, we observed that ILFs from aged animals had ele-
vated production of IgA. Evaluation of the B-lymphocyte
immunoglobulin repertoire revealed that the ILF B-lym-
phocyte population was reflective of the systemic B-cell
population and developed a skewed VH usage in aged
mice. These observations indicate that ILFs are altered
with aging and that ILF dysfunction contributes to muco-
sal immunosenescence.
Results
ILF formation is augmented at an early stage with aging
ILFs and CP are components of a spectrum of lymphoid
aggregates that have been termed solitary intestinal lym-
phoid tissue (SILT) [20]. CPs are clusters of unique lym-
phoid tissue inducer like cells lacking expression of
surface markers defining mature bone marrow derived
lineages. These clusters act as nascent lymphoid tissues
giving rise to ILFs in response to inflammatory stimuli.
As CP progress to become ILFs they become infiltrated
with a substantial population of dendritic cells [23], and
accordingly the presence of CD11c+ clusters can be
used to identify stages of SILT ranging from CP pro-
gressing to immature ILFs to fully developed mature
ILFs. In comparison to CP, ILFs are larger, more com-
plex cellular aggregates containing mature B- and
T-lymphocytes. ILFs can range from lymphocyte con-
taining cellular clusters encompassing the crypt and
extending up the villi to more organized aggregates hav-
ing a follicular appearance possessing an overlying folli-
cle associated epithelium (FAE). ILFs in all stages of
development can be identified as clusters of B220+ cells
and the more developed or mature ILFs can be identi-
fied by their nodular appearance and FAE identified
with Ulex europaeus (UEA-I) staining.
To begin assessing the impact of aging on ILF forma-
tion, we examined the number of SILT at various stages
of development in young and aged mice. We noted that
the numbers of mature ILFs (mILFs), or fully developed
ILFs, in the intestines of the aged mice were significantly
higher than those of the young mice (Figure 1a). Consis-
tent with the increased number of mILFs, we observed
that the aged mice had a significantly increased number
of immature ILFs (iILFs), or B-lymphocyte containing
structures that are not fully developed, when compared
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to young mice (Figure 1b). We also observed an
increased number of CD11c+ clusters identifying com-
ponents of the SILT spectrum encompassing CP transi-
tioning to iILFs and mILFs (Figure 1c). Prior reports
indicate that the numbers of CP are relatively static, and
we observed no difference in the numbers of CP
between aged and young animals (not shown). Studies
in young animals indicate that the influx of CD11c+
cells in response to inflammatory stimuli is an early
event in the transformation of CPs into ILFs [23]. In
conjunction with our findings of augmented ILF devel-
opment with aging, this suggests that during aging the
intestine is subject to chronic inflammation.
The cellular composition of the ILFs is altered with aging
The cellular composition of ILFs in young mice resembles
that of PP and lymph nodes, and includes B-lymphocytes,
T-lymphocytes (CD4 or CD8 single positive), and dendri-
tic cells [19-21]. To gain insight into the function of ILFs
in aging, we examined the cellular compositions of ILFs in
aged and young mice using flow cytometry. We found that
in comparison to young mice, the aged mice had a smaller
population of B-lymphocytes (CD19+ cells) and an
increased population of T-lymphocytes (TCRb+ cells)
(Figure 2a, 2b). We observed no significant differences in
the antigen presenting cell population (CD19-, MHC II+)
from the young and aged mice (Figure 2c). Further analy-
sis of the increased T-lymphocyte population from aged
mice revealed the presence of a unique CD4+ CD8a+
(double positive) TCRb+ population (Figure 3a). These
double positive T lymphocytes were rare in spleen and the
PPs of the aged mice. The double positive cells repre-
sented 2.33 +/- 0.145% and 19.05 +/- 3.55% (mean +/- SD)
of the total ILF cellular population falling within the lym-
phocyte gate for the young and aged mice, respectively.
CD8 is a transmembrane glycoprotein that binds to class I
MHC proteins and serves as a co-receptor for TCR. It
forms a dimer, most commonly consisting of CD8a and
CD8b (CD8ab+ heterodimer). Less commonly, homodi-
mers of two CD8a chains are also expressed. Further ana-
lysis of the CD4+CD8a+ cells from ILFs of the aged mice
revealed that these cells did not express CD8b, and hence
are CD4+ CD8aa+ TCRb+ T-cells (Figure 3b). Likewise
the minor population of CD4+ CD8a+ T-cells from the
PP of aged mice were CD8b-, while the spleen of aged
mice did not contain a CD8a+ CD8b- population (Figure
3b). The ILFs and PP of aged mice also contained CD4-
CD8aa+ and CD4- CD8ab+ populations, while CD4-
CD8aa+ populations were largely absent from the spleen
(Figure 3b).
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Figure 1 ILF formation is augmented at an early stage with aging. To evaluate if the process of ILF development was altered with aging,
whole mount techniques were used to identify well developed SILT containing a follicle associated epithelium indicative of mature ILFs (panel
a), poorly developed or immature ILFs comprising a loose cluster of B-lymphocytes (panel b), and nascent lymphoid tissues transitioning into
ILFs as identified by CD11c+ clusters (panel c) in young and aged mice. Aged mice had significantly increased numbers of mature ILFs (panel a),
immature ILFs (panel b), and CD11c+ clusters (panel c), indicating that all stages of CP transitioning into ILFs are augmented with aging. n = 3
or more mice in each group. * = p < 0.05.
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Figure 2 ILFs from aged mice have an aberrant cellular composition. The cellular composition of ILFs isolated from aged and young mice
was evaluated using multi-color flow cytometry. ILF cellular populations from aged mice had a significantly decreased population of B-
lymphocytes (panel a) and a significantly increased population of T-lymphocytes (panel b). The population of antigen presenting cells (APCs) was
not significantly different between aged and young mice. n = 3 or more mice in each group. * = p < 0.05.
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ILFs from aged mice have altered expression of
chemokines and chemokine receptors required for ILF
development
We previously reported that CC chemokine receptor-6
(CCR6) and its ligand CCL20 are highly expressed
within ILFs and that B-lymphocytes are the largest
CCR6-expressing population within ILFs [18]. Further-
more, CCR6-sufficient B-lymphocytes are essential for
the formation of ILFs [18]. Prior studies have demon-
strated that CXC chemokine receptor-5 (CXCR5) and
its ligand, CXCL13 or B-lymphocyte chemoattractant
(BLC), are required for the migration of B lymphocytes
to organized lymphoid follicles and the development of
PP and SILT [23-25]. To assess the roles of these che-
mokines and their receptors in the age-related augmen-
tation of SILT formation and aberrant ILF cellular
populations, we examined the mRNA expression of
CCR6, CCL20, CXCR5, and CXCL13 in ILFs using real-
time polymerase chain reaction. We noted that the
mRNA expression of chemokines CCL20, CXCL13, and
their receptors CCR6 and CXCR5 were significantly
lower in ILFs of the aged mice than in those of the
young mice, which correlated with decreased expression
of CCL20 and CXCL13 protein in the intestine of aged
mice (Figure 4). These factors are essential for B-lym-
phocyte homing to lymphoid follicles, and their
decreased expression is in agreement with the smaller
B-lymphocyte population in the ILFs of aged mice.
Aged mice produce higher levels of systemic and
mucosal immunoglobulins
The literature on immunoglobulin production in aged
animals and humans is limited and somewhat conflict-
ing. Some studies have reported increases or no change
in the serum IgA levels in old animals and humans
[26-29]. A few studies also reported the absence of age-
related differences in the amounts of nonspecific immu-
noglobulins secreted into the intestinal lumen in vivo or
into the medium by cultured duodenal biopsies [28-31],
while other studies observed that the production of anti-
gen-specific IgA is diminished with aging [14,32,33].
We observed significantly elevated levels of IgA, IgG
and IgM in the serum of the aged mice (Figure 5a-c),
and increased levels of IgA in the feces of aged mice
(Figure 5d). ILFs preferentially induce B-lymphocytes to
become IgA producing plasma cells [22]. To evaluate
the contribution of the ILFs to the increase in fecal IgA
with aging, we isolated and cultured ILF cellular popula-
tions and evaluated the IgA levels in the culture super-
natant. Consistent with ILFs contributing to the increase
in fecal IgA with aging, we found that ILFs from aged
mice had elevated IgA production (Figure 5e).
ILF immunoglobulin repertoire reflects the systemic
compartment and becomes skewed with aging
The development of ILFs is not completely understood,
with some studies suggesting that ILFs develop from the
Figure 3 ILFs from aged mice contain a population of CD4+ CD8aa+ T-lymphocytes. ILF, PP, and splenocyte populations from young and
aged mice were isolated and evaluated by multi-color flow cytometry for the presence of CD4+ and CD8a+ T-lymphocytes (panel a). ILFs from
aged mice contained a significant population of CD4+ CD8a+ T-cells, which was largely absent from the spleen and PP of aged mice and from
the ILFs of young mice (panel a). Further analysis of the CD4+ CD8a+ population within ILFs from aged mice revealed that this population was
CD8b-, and therefore CD8aa+ (black line histogram panel b). This CD4+ CD8aa+ T-lymphocyte population was also present in PP from aged
mice, but absent from the splenocyte population of aged mice (black line histogram panel b). Within the ILF and PP population from aged mice
the CD4- CD8a+ T-lymphocytes were both CD8b+ and CDb-, while in the spleen this population was only CD8b+ (gray line histograms panel
b). Data shown are representative of two or more experiments.
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recruitment of peripheral B-lymphocytes and others sug-
gesting that B-lymphocytes within ILFs expand in situ to
generate follicles. In support of the former possibility we
previously reported that individual ILFs from young mice
contain a population of polyclonal B-2 B lymphocytes
that was reflective of the systemic pool of B-lymphocytes
[22]. Consistent with the second possibility, others
reported that the predominant immunoglobulin VH gene
used within individual ILFs in aged activation-induced
cytidine deaminase (AID)-deficient mice varied, suggest-
ing that different B-lymphocytes expand within individual
ILFs skewing the immunoglobulin repertoire usage such
that it was not reflective of the systemic compartment
[34]. While these two possibilities are not mutually exclu-
sive, they could suggest different pathways by which the
number of ILFs would expand during aging; with the for-
mer implying that the increased number of ILFs occurs
by recruitment of B-lymphocytes representative of the
systemic pool and the latter that increased ILF develop-
ment results from expansion of B-lymphocytes within the
ILFs, possibly reflective of a B-lymphocyte intrinsic pro-
cess. To address these possibilities, we analyzed the
immunoglobulin heavy chain repertoire usage within the
spleen, PP, and individual ILFs from young and aged
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Figure 4 ILFs from aged mice express lower levels of chemokines and chemokine receptors demonstrated to play a role recruiting
B-lymphocytes into ILFs. RNA was isolated from pooled ILFs from aged and young mice. The mRNA expression of CCL20, CXCL13, CCR6, and
CXCR5 was evaluated using real time PCR (panel a), and the protein expression for intestinal CCL20 and CXCL13 was measured by ELISA (panel
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mice. We observed that the VH usage within ILFs from
young mice was diverse, indicative of a polyclonal popu-
lation, paralleling that of the spleen, which is representa-
tive of the systemic pool (Figure 6a-d). Likewise, in the
aged mouse the VH usage within all the ILFs examined
was highly reflective of that seen in the spleen, and thus
reflective of VH usage within the systemic compartment
(Figure 6a-d). While both young and old mice had a simi-
lar usage of VH families, with VH1, VH2, and VH14 repre-
senting greater than 80% of the VH families used by both
groups, the usage of an individual VH family became
more skewed with aging as the VH1 family became the
predominant family used in each tissue, representing
over 60% of the VH family usage overall.
Discussion
Immunosenescence is a state of dysregulated immune
function contributing to the increased susceptibility of
the elderly to infection, autoimmune diseases, chronic
inflammatory diseases, and cancer [1-4]. The majority of
studies on immunosenescence have examined the sys-
temic immune system and support that systemic immu-
nity is affected with aging. Studies of the impact of
aging on the mucosal immune system are less numer-
ous, however emerging data more directly suggests an
affect of aging on the mucosal immune system. Age
greater than 65 has been identified as an independent
risk factor for the development of C. difficle colitis [35],
an enteric infection whose recurrence and clinical
course are related to the production of anti-toxin speci-
fic IgA in the intestinal lumen [36]. Aging is associated
with a decreased ability to produce antigen specific
immunoglobulins, including IgA, following mucosal
immunization [32,37-39], implying a direct impact of
aging on the mucosal immune system, with a resultant
increased risk of enteric infection. While it is becoming
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Figure 6 ILFs from young and aged mice contain a B-lymphocyte repertoire that is reflective of the systemic B lymphocyte pool; the
B-lymphocyte repertoire becomes skewed with aging. RNA isolated from the spleen, PP, and individual ILFs from a young and aged mouse
was transcribed into cDNA and immunoglobulin genes amplified using a universal VH primer and a constant IgM region primer. Gel-purified
products were ligated into vectors and individual clones containing the appropriate size insert were sequenced and assigned to a VH family.
Analysis of all clones identified from the young (left) and aged mice (right) revealed a similar preferential usage of VH families with VH1, VH2, and
VH14 representing greater than 80% of the VH families used by either mouse (panel a). With aging, the Ig repertoire became more skewed with
dominant usage of the VH1 family (panel a right). Comparison of the VH usage within the spleen (panel b), reflective of the systemic pool, to the
PP (panel c) and individual ILFs (panel d) revealed similar VH usage between these tissues within aged and young mice and revealed that the Ig
repertoire was skewed toward dominant VH1 usage in all tissues in the aged mouse (panels b-d right).
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more clear that the mucosal immune system is affected
by aging, the components of the mucosal immune sys-
tem that are affected by aging and the functional conse-
quences of these changes are still largely unexplored.
Organized lymphoid tissues play a crucial role in
immunity by providing sites for the efficient interactions
of antigens, antigen presenting cells, and lymphocytes.
These structures are essential for the initiation of pri-
mary immune responses, and the regulated environment
they provide is believed to be necessary to prevent inap-
propriate immune responses. Traditionally the organized
lymphoid tissues of the intestine were thought to be
limited to secondary lymphoid structures, or Peyer’s
patches (PP). The foundations for PP formation only
occur during embryogenesis, and therefore the number
and positioning of PP are fixed throughout life [40-43].
Recent studies have shown that the adult intestine con-
tains an additional population of organized lymphoid
tissues, or solitary intestinal lymphoid tissues (SILT).
SILT are a continuum of lymphoid tissues that have a
unique plasticity allowing for the development and
regression of a fully functional lymphoid tissue that can
mediate homeostatic responses [17,19-21]. Within this
continuum, CP act as nascent lymphoid tissues that
sequentially become invested with dendritic cells and B-
lymphocytes, to become ILFs [23]. Poorly developed, or
immature ILFs (iILFs), can subsequently expand and
develop a dome like structure with a follicle associated
epithelium (FAE) to become mature ILFs (mILFs),
which have the potential to initiate controlled adaptive
immune responses to luminal antigens [21]. The murine
intestine contains ~1000 SILT, and therefore in contrast
to PP which are fixed and more limited in number
(~10), SILT have a greater potential to act as sites for
the induction of intestinal immune responses and con-
versely to be affected by immunosenescence.
There is precedence for newly developed lymphoid tis-
sues to contribute to chronic inflammatory and autoim-
mune pathologies. Inducible lymphoid tissues, are
markedly increased in conditions with inappropriate
immune responses, such as those seen in inflammatory
bowel disease (IBD) [20]. These aberrantly formed or
tertiary lymphoid tissues have been proposed to initiate
or propagate the inappropriate responses seen in auto-
immune and chronic inflammatory conditions and har-
bor the earliest manifestations of IBD [44,45]. Thus it is
possible that ILFs formed aberrantly as a result of
immunosenescence might subsequently contribute to
immune dysfunction and participate in the increased
incidence of IBD seen in the seventh decade of life.
Here we demonstrate that ILF formation is augmented
with aging. We observed that the numbers of CPs con-
taining DCs, iILFs, and mILFs were significantly
increased in the aged mice. Aged mice were on average
25% larger than their gender and strain matched coun-
terparts; average of 28.4 gm vs. 22.6 gm for 17 month
old vs. 11 week old female Balb/c mice (information
from the National Institute on Aging rodent colony).
While this increase in body size could translate to a pro-
portional increase in the number of ILFs, alone it is not
sufficient to explain the three-fold increase in ILFs we
observed. Furthermore, the cellular compositions of ILFs
from the aged mouse are abnormal with a decreased B-
lymphocyte population and the appearance of CD4
+CD8+ double positive T-lymphocytes. To assess the
factors contributing to the decreased B lymphocyte
population in ILFs with aging, we examined the expres-
sion of the chemokines CCL20 and CXCL13, which
have been demonstrated to play a role in recruiting B-
lymphocytes into SILT [18,23,25]. Similar to the process
of ILF formation, the production of CCL20 is induced
by inflammatory conditions, and CCR6, the only identi-
fied receptor of CCL20, is expressed by B-lymphocytes
[46-49]. CCR6 is required for the development of ILFs
and CCR6 deficient B-lymphocytes have reduced ability
to localize to PPs and ILFs [18]. In a similar fashion,
CXCR5 expression by B-lymphocytes is required for the
development of ILFs, and ILF dendritic cells were iden-
tified as sources for CXCL13 production to support ILF
development [23,25]. CXCL13 not only recruits CXCR5
+ B-lymphocytes, but also induces the expression of
lymphotoxin (LT) by antigen-naïve B-lymphocytes,
which further induces the production of CXCL13 by
lymphotoxin beta receptor (LTbR) expressing stromal
cells [24]. In addition, LT expression by B-lymphocytes
is required for the development of SILT with large folli-
cles, or mature ILFs [17]. Since CCR6+ B lymphocytes
are also CXCR5+ [50], CCL20 and CXCL13 may act
synergistically to recruit antigen naïve B-lymphocytes
into ILFs and promote the development of mature folli-
cles via LT/LTbR pathways. We observed a significant
decrease in the expression of CCL20, CXCL13, and
their respective receptors CCR6 and CXCR5 in the ILFs
of aged mice when compared with those of the young
mice. The decreased expression of CCL20 and CXCL13
and resultant decreased B-lymphocyte population in the
ILFs of the aged mice is consistent with these previously
observed functions of CCL20 and CXCL13. The combi-
nation of a decreased expression of these chemokines
and a decreased ILF B-lymphocyte population with a
paradoxical increase in the number of ILFs suggests that
alternative pathways may be emphasized in ILF develop-
ment during aging.
Peripheral T-lymphocytes are generally grouped into
two subsets on the basis of the mutually exclusive cell
surface expression of the CD4 and CD8 co-receptors.
The expression of the CD4 or CD8 co-receptors by
mature peripheral T-lymphocytes defines function
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specific differences (helper vs. cytolytic function respec-
tively) as well as differences in major histocompatibility
complex (MHC) restriction (MHC II vs. MHC I respec-
tively). An exception to this generalization in which
mature peripheral T-lymphocytes express both CD4 and
CD8 co-receptors has been noted across many species
[51-54]. The double positive cells can be grouped on the
basis of CD8b expression, i.e. CD4+CD8aa+ and CD4
+CD8ab+. There is evidence that the CD4 and CD8 co-
receptors are functional in these double positive cells
[55-57]. Regulating these double positive cells would be
complex, as they could be more prone to generating
inappropriate responses due to the multiplicity of recep-
tors. The origin and function of the double positive cells
is unclear. They have been suggested to be 1) recent thy-
mic emigrants that are precursors of single positive cells,
2) single positive cells that have upregulated expression
of the reciprocal coreceptor upon activation, 3) extrathy-
mic T lymphocytes generated within the intestine, at the
sites of CP, in response to the involution of the thymus
with aging, or 4) T lymphocytes that were aberrantly
selected in the thymus [53,54,56,58,59]. The double posi-
tive cell were less common in PP and rare in the spleen
of aged animals, supporting the preferential localization
of this rare T-lymphocyte population to the intestinal
mucosa. Double positive T-lymphocytes have been noted
to accumulate in the peripheral blood and intraepithelial
lymphocyte compartment with aging [54,55,59,60] and in
target organs affected in autoimmune and chronic
inflammatory conditions such as atopic dermatitis, sys-
temic sclerosis, and autoimmune thyroid disease, sug-
gesting that these cells may be responsible for the
pathologic immune responses seen in these conditions
[59]. Coupled with our observations, this suggests that
with aging ILFs become sites of dysregulated immune
responses potentially contributing to the increased inci-
dence of IBD with aging.
A characteristic feature of the mucosal immune sys-
tem is its ability to produce and secrete IgA. Some stu-
dies reported the absence of age-related differences in
the amounts of nonspecific immunoglobulins secreted
into the intestinal lumen in vivo or into the medium by
cultured duodenal biopsies, while others reported that
the level of IgA increased in the intestinal juice from
aged mice [31,61]. The sources contributing to lumenal
IgA are complex and include both B1 and B2 lympho-
cytes arising from the systemic immune system, mucosal
immune system, and the peritoneal cavity. Mature ILFs
are sites for the generation of IgA producing plasma
cells from B2 B-lymphocyte precursors in response to
lumenal antigens [21,22]. Therefore alterations in ILF
development and/or function with aging could impact
IgA production and mucosal protection. We observed
that with aging IgA was significantly elevated in the
serum (~ 2 fold) and further elevated in the feces (~ 4
fold), implying a mucosal source that contributes to
these elevated fecal IgA levels. While the relative contri-
bution of each of the above mentioned sources to the
elevated mucosal IgA levels can not be determined, the
increased number of mature ILFs (~3 fold) seen with
aging and the increased production of IgA by ILF cellu-
lar populations (~ 5 fold) with aging are consistent with
ILFs as contributors to the increased lumenal IgA and
suggest that they become a more significant contributor
to lumenal IgA with increasing age. The increased IgA
seen in the aged ILFs occurs despite the decreased
population of ILF B-lymphocytes. In concert with the
increased number of ILFs, this further suggests the
mucosal immune system becomes dysregulated with
aging.
B-lymphocytes are a prominent hematopoietic cellular
population within ILFs. The sources of B-lymphocytes
that contribute to the emergence of the developing SILT
are not completely understood, but they may originate
from two sources that are not mutually exclusive and
include B-lymphocytes that are recruited from the sys-
temic pool or B-lymphocytes that expand in situ to gen-
erate ILFs. To better understand how ILFs are generated
during aging we evaluated the immunoglobulin reper-
toire usage within ILFs and compared it to the systemic
pool as represented by the immunoglobulin repertoire
usage within the spleen. We observed that in both
young and aged mice the ILF immunoglobulin reper-
toire was reflective of that seen in the spleen. Like prior
studies we also observed that B-lymphocyte repertoire
usage becomes less diverse with aging [62]. However,
this skewed repertoire usage was consistent throughout
the tissues evaluated in the aged mice further supporting
that ILF B-lymphocytes are recruited from the systemic
pool. Multiple factors could contribute to the skewing
of the B-lymphocyte repertoire, including diminished
B-lymphocyte precursors and expansion of oligoclonal
B-lymphocyte populations [63]. Skewing of the B-
lymphocyte repertoire with aging is associated with poor
health [62], and the observation that this also occurs
within the mucosal immune compartment is further evi-
dence that the mucosal immune system is impacted by
aging and adversely affected by immunosenescence.
Conclusions
ILFs are recently recognized contributors to mucosal
immunity acting as a reservoir of inducible sites for the
generation of adaptive immunity including T-lympho-
cyte dependent and independent IgA responses[21,64].
Emerging epidemiologic observations implicate mucosal
immunosenescence as a risk factor for enteric infections,
autoimmunity, and malignancy. Here we provide evi-
dence to support these epidemiologic observations and
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demonstrate that like the components of the systemic
immune system, aging impacts these recently recognized
contributors to mucosal immunity.
Methods
Mice
Female BALB/c mice of indicated age were purchased
from National Institute on Aging (NIA) and were
housed in a specific pathogen free facility and fed rou-
tine chow diet. Young mice were 8-12 weeks old, and
old mice were 21-23 months old. Mice were housed for
at least 2 weeks prior to experiments to allow the muco-
sal immune system to accommodate to changes in bac-
terial flora. No differences in the measured parameters
were observed with longer periods of housing. Animal
procedures and protocols were carried out in accor-
dance with the institutional review board at Washington
University School of Medicine.
Whole mounts of small intestine
Small intestines were removed intact, flushed with cold
PBS, and opened along the mesenteric border. Intestines
were mounted, lumen facing up and fixed with cold 10%
buffered formalin phosphate (Fisher Scientific) for 1 h at
4°C. Intestines were washed three times in cold PBS,
incubated in a solution of 20 mM DTT, 150 mM Tris,
and 20% ethanol at room temperature for 45 min,
washed three times in cold PBS, and incubated in a solu-
tion of 1% H2O2 for 15 min at room temperature to
block endogenous peroxidases. Intestines were washed
three times in PBS, followed by incubation in PBS con-
taining 1% BSA and 0.3% Triton X-100 for 30 min. Intes-
tines were incubated with HRP-conjugated lectin from
Ulex europaeus (UEA-I) (Sigma-Aldrich, St. Louis, MO)
in PBS containing BSA and Triton X-100 overnight at 4°
C to facilitate the identification of PP and mature ILF
(mILF). The following day, intestines were washed three
times in PBS, incubated in DAB metal peroxide substrate
(Pierce, Rockford, IL) for 15 min, rinsed twice in distilled
water, and returned to PBS for further analysis. Under
low-power microscopy (25-65X) the following criteria
were used to determine the presence of mILF: 1) pre-
sence of a nodular structure with size equal to or greater
than the width of one villus, 2) nodular structure posses-
sing an overlying dome resembling the FAE of PP, and 3)
nodular structures occurring singly or in groups of two
(three or more nodules of approximately the same size
were considered to be PP).
For anti-B220 and anti-CD11c staining of whole
mounts to determine the numbers of immature ILFs
(iILFs) and CD11c+ clusters, identifying CP transitioning
into ILFs and ILFs, intestines were removed intact,
flushed with PBS, opened along the mesenteric border,
and mounted as above. Intestines were then incubated
three times in HBSS (BioWhittaker, Walkersville, MD)
containing 5 mM EDTA at 37°C with shaking for
10 minutes to remove epithelial cells. Intestines were
then fixed in 10% buffered formalin phosphate and trea-
ted with 1% H2O2 for 15 minutes at room temperature
as above. Intestines were incubated in a solution of 50
mM Tris pH 7.2, 150 mM NaCl, 0.6% Triton-X 100,
and 0.1% BSA for one hour at 4°C to block non-specific
antibody binding and then incubated with rat anti-
mouse B220 antibody or biotin conjugated hamster anti-
mouse CD11c (both from BDbiosciences, San Diego,
CA) diluted in the above solution overnight at 4°C.
Intestines were washed three times in the above solution
and incubated with a horseradish peroxidase conjugated
goat anti-rat IgG antibody or streptavidin conjugate
horseradish peroxidase (Jackson ImmunoResearch
Laboratories, West Grove, PA) diluted in the above
solution at room temperature for one hour. Intestines
were washed three times and incubated in DAB metal
peroxide substrate as above. Intestine whole mounts
were examined under a dissecting microscope at
25-65X. Immature ILFs (iILFs) were counted as clusters
of B220+ cells occurring at the base of villi and not con-
taining an overlying dome. Dendritic cell clusters were
counted as clusters of CD11c+ cells occurring at the
base of villi [17,20].
Isolation of cellular populations from spleen, PP, and ILFs
Spleens and PP were removed from BALB/c mice and
disrupted by mechanical dissociation. Intestines were
flushed with cold PBS, opened along the mesenteric
border, and mounted with the lumen facing up in cold
PBS, as described above. PP were identified, cut out, and
disrupted using mechanical disassociation. Using a dis-
secting microscope and a blunt-end 26-gauge needle
and syringe, the contents of multiple mILFs were aspi-
rated and placed in cold PBS. RBC were lysed from each
cellular suspension and then used for flow-cytometric
analysis as described below. Average yield of viable
mononuclear ILFs cells ranged from 3-7 × 105 cells/
intestine [17].
ELISAs for immunoglobulins, CCL20, and CXCL13
Feces were collected from individual mouse, diluted 1/
10 wet weight to volume with PBS, vortexed into a uni-
form suspension, and centrifuged at 12,000 rpm for 10
min in a tabletop microcentrifuge, and supernatants
were harvested. Coagulated mouse blood samples from
individual mice were centrifuged and the sera collected.
ILF cellular populations were isolated and cultured for
five days as previously described[22]. Immunoglobulin
levels were measured in fecal supernatants, serum, and
culture supernatants by ELISA as previously described
[22]. CCL20 and CXCL13 were measured in protein
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lysates obtained from sections of intestine from aged
and young mice using commercially available assays
(R and D systems, Minneapolis, MN) per the manufac-
turers recommendations.
Flow Cytometric Analysis
Single cell suspensions, obtained as above were used for
flow cytometric analysis. Briefly, single cell suspension
were resuspended in PBS with 1% BSA (Fisher Scienti-
fic) and 1 mg/ml human IgG (Sandoz Pharmaceuticals,
East Hanover, NJ) at 2 × 107 cells/ml. Cells were incu-
bated with antibodies for 30 min on ice in the dark.
Cells were washed in PBS and fixed with 1% paraformal-
dehyde in PBS. Events were analyzed using a FACScan
cytometer (BDbiosciences) retrofitted with a second
laser. Data acquisition was performed using Cellquest
(BDbiosciences) and Rainbow (Cytek, Fremont, CA)
software. Dead cells were excluded based on forward
and side light scatter. Gates for positive staining were
defined such that 1% of the analyzed population stained
positive with the appropriate isotype control antibodies
(all from BD Biosciences).
RNA isolation and real-time polymerase chain reaction
Mature ILFs were isolated from both young and aged mice
using a dissection microscope and 26-gauge blunt needle
as described above. The aspirates containing the overlying
FAE, stromal elements, and mononuclear cells from the
same mouse were pooled together. RBCs were lysed from
each cellular suspension. RNA was isolated using the Arc-
turus PicoPure RNA isolation kit (Applied Biosystems,
Foster City, CA), and treated with DNase I (Ambion, Aus-
tin, TX) to remove contaminating DNA. cDNA was
synthesized from 2 μg of total RNA using Superscript II
RNase H- reverse transcriptase (Invitrogen, Carlsbad, CA).
Expression of targets was detected by real time PCR using
ABI prism 7700 sequence detection system and SYBR
Green PCR master mix (Applied Biosystems). The follow-
ing primers were used for detection of the targets, forward
primers are listed first followed by reverse primers: 18S 5’-
CGGCTACCACATCCAAGGAA-3’ and 5’-GCTGGAAT-
TACCGCGGCT-3’, b-actin 5’-GCTTCTTTGCAGCT
CCTTCGT-3’ and 5’-ATATCGTCATCCATGGCGAAC-
3’, CCL20 5’-TGATGCTTTTTTGGGATGGAA-3’ and
5’-AGCCTTCAACCCCAGCTGT-3’, CCR6 5’-TGTTC
TGCTATCTGTTCATTATCAAGA-3’ and 5’-CACGA
CTCGGATGGCTCTGT-3’, CXCR5 5’-GGGCCCCTG
TCTGTTTCTGT-3’ and 5’-GCCCAAGCTCGAGTTG-
GAT-3’, and CXCL13 5’-CAGAATGAGGCTCAGCA-
CAGC-3’ and 5’-CAGAATACCGTGGCCTGGAG-3’.
Samples were measured in triplicate. Relative quantitation
of target expression using 18S or b-actin as a housekeep-
ing gene was determined using the comparative CT
method as described in the ABI Prism 7700 sequence
detection system user bulletin.
Immunoglobulin heavy chain repertoire analysis
Single cell populations from spleen, PP, and individual
ILFs were isolated as described above and the RNA was
isolated using the Arcturus PicoPure RNA isolation kit.
cDNA was synthesized using the isolated RNA as tem-
plate as described previously. The immunoglobulin genes
were amplified with PCR using a universal VH primer 5’-
AGGTSMARCTGCAGSAGTCWGG-3’ in combination
with an IgM constant region primer 5’- CCCTGGAT-
GACTTCAGTGTTG - 3’[65]. Amplified products were
ligated into the pCR-BluntII-TOPO vector (Intivtrogen
Corporation, Carlsbad, CA) and plasmids were isolated
from individual clones and sequenced. Sequences were
analyzed using The International Immunogenetics Infor-
mation System (IMGT/V-Quest). Four hundred and
forty seven individual clones were sequenced of which
298 clones could be definitively assigned to a VH family.
Statistical analysis
Data analysis using Student’s t test and one-way
ANOVA followed by Tukey’s multiple comparisons
post-test was performed using GraphPad Prism (Graph-
Pad Software). A value of p < 0.05 was used as a cutoff
for statistical significance.
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